Work

New FDA-Approved Treg Therapy to Reduce Chronic GVHD After Allogeneic HSCT

Year: 2026

Type: article

Source: Blood

DOI: 10.1182/blood.2026035591

Author: Nelson J. Chao

Institution: Duke Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7215684659

FWCI:

Cites:

Cited by:

Related to: